NEW YORK, Nov 3 – Applied Biosystems and DeCode Genetics officially announced Friday that DeCode has purchased 50 ABI Prism 3700 DNA Analyzers as part of its efforts to genotype the Icelandic population.
GenomeWeb first reported this deal in September.
Terms of the transaction were not disclosed but t he price for the 3700 sequencer is $250,000, not including any discounts that big buyers may receive.
Over the past two years, Applied Biosystems has sold about 2,000 of the 3700 units.
DeCode said the 3700s would help it to increase its average genotyping throughput nearly fivefold to about 12 million genotypes a month.
In addition to its genotyping efforts, DeCode is also planning to begin commercializing its informatics tools in the near future. The company expects to announce a deal to provide its software to an unnamed customer in the next couple of months.